Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Review

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

         
Total article views   Abstract views HTML views PDF downloads Totals
1,634 Dovepress* 793 841+ 320 1,634
Totals 793 841 320 1,634
*Since 5 March 2021
+Since July 2016

View citations on Google Scholar